Accessibility Menu
Albemarle logo

Albemarle(NYSE) ALB

Current Price$114.40
Market Cap$13.54BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1994)+2,529%
5 Year-36%
1 Year+38%
1 Month-22%
Albemarle last closing stock price
MetricPriceDate
Last closeUSD 114.852026-07-24
Albemarle stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.91%USD 120.782026-07-17
1 month-22.31%USD 147.842026-06-24
3 month-38.86%USD 187.852026-04-24
Year to date-18.39%USD 140.732025-12-31
1 year+38.28%USD 83.062025-07-24
3 year-43.41%USD 202.962023-07-25
5 year-35.97%USD 179.372021-07-23
Since inception+2,529.04%USD 4.371994-02-22

Albemarle Financials at a Glance

Market Cap

$13.54BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$5.49B

Net Income (TTM)

-$232.89M

EPS (TTM)

-$3.41

P/E Ratio

-33.64

Dividend

$1.62

Beta (Volatility)

1.58 (High)

Price

$114.40

Volume

25,054

Open

$116.44

Previous Close

$114.85

Daily Range

$113.80 - $117.00

52-Week Range

$64.95 - $221.00

Estimated Earnings Date

Aug 5, 2026

ALB: Motley Fool Moneyball Superscore

58

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Albemarle

Albemarle creates the essential ingredients used in electric vehicle batteries and smartphones. The company helps the world move and communicate by refining raw materials into specialty chemicals. These products allow manufacturers to make cars, electronics, and medicine safer and more efficient.

What Albemarle Makes

  • Energy Storage: Refines lithium into compounds like carbonate and hydroxide for electric vehicle batteries and power grids.
  • Specialties: Produces bromine and lithium solutions for high-voltage cables, airbags, and pharmaceutical manufacturing.
  • Ketjen: Provides catalysts that help oil refineries remove impurities and create cleaner transportation fuels.

Recent Strategic Moves

  • Signed a 2025 agreement to divest the Ketjen refining solutions business to ChemCat AcquisitionCo, LLC.
  • Completed the sale of a 50% stake in Eurecat S.A. to Axens SA in January 2026.
  • Restructured the MARBL joint venture in October 2023 to gain full ownership of the Kemerton processing facility.
  • Placed the Kemerton Train 1 facility into care and maintenance to manage production costs.

Global Reach and Innovation

The company operates more than 25 production and research sites across the Americas, Asia Pacific, Europe, and the Middle East. It manages proprietary extraction technology and holds over 1,500 active patents to maintain its position in the specialty chemicals market.

By the Numbers

  • Net sales reached $1.4 billion in Q4 2025, up 15.9% from Q4 2024.
  • Operating income rose to $48.3 million in Q4 2025, up 411.1% year-over-year.
  • Free cash flow hit $233.1 million in Q4 2025, up 165.7% from the previous year.
  • Operating cash flow grew to $388.5 million in Q4 2025, up from $674,000 in Q4 2024.

The Bottom Line

Albemarle has transitioned into a major supplier for the global transition to electric energy. By focusing on lithium and bromine while divesting traditional refining units, the company continues to align its portfolio with high-growth technology markets.

AI Generated • Apr 19, 2026

Industry

Chemicals

Sector

Materials

Employees

7,800

CEO

Jerry Kent Masters, Jr., MBA

Headquarters

Charlotte, NC 28209, US

ALB Financials

Key Financial Metrics (TTM)

Gross Margin

18.53%

Operating Margin

5.55%

Net Income Margin

-4.24%

Return on Equity

-2.35%

Return on Capital

0.73%

Return on Assets

-1.54%

Earnings Yield

-2.97%

Dividend Yield

1.41%

Payout Ratio

-1.53%

Stock Overview

Market Cap

$13.54BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

117.94M

Volume

25.05K

Avg. Volume

2.26M

Financials (TTM)

Gross Profit

$1.02B

Operating Income

$305.04M

EBITDA

$747.07M

Operating Cash Flow

$1.08B

Capital Expenditure

-$505.85M

Free Cash Flow

$577.28M

Cash & ST Invst.

$1.09B

Total Debt

$1.88B

Albemarle Performance Analysis

Albemarle annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 7,320,104,000120.0%
20232023-12-31USD 9,617,203,00031.4%
20242024-12-31USD 5,377,526,000-44.1%
20252025-12-31USD 5,142,733,000-4.4%
Albemarle sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3023.5%
Q32025-09-30-1.7%
Q42025-12-319.2%
Q12026-03-310.0%
Albemarle annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 22.842051.8%
20232023-12-31USD 13.36-41.5%
20242024-12-31USD -11.20N/A
20252025-12-31USD -5.76-48.6%
Albemarle sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-5417.2%
Q32025-09-30-975.0%
Q42025-12-31-125.0%
Q12026-03-31160.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$1.43B

+32.7%

Gross Profit

$500.97M

+224.5%

Gross Margin

35.06%

N/A

Market Cap

$13.54BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.74M

N/A

Employees

7,800

N/A

Net Income

$319.09M

+671.7%

EBITDA

$445.12M

+72.6%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$1.09B

-28.2%

Total Debt

$1.88B

-48.3%

Accounts Receivable

$659.48M

-18.4%

Inventory

$1.35B

-18.7%

Long Term Debt

$1.81B

-44.0%

Short Term Debt

$74.63M

-81.8%

Return on Assets

-1.54%

N/A

Return on Invested Capital

2.25%

N/A

Free Cash Flow

$247.57M

-31.8%

Operating Cash Flow

$346.24M

-36.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RPMRPM International Inc.
$107.87+0.81%
JHXJames Hardie Industries plc
$26.65+0.40%
SUZSuzano S.A.
$8.21-1.03%
RGLDRoyal Gold, Inc.
$201.53+0.28%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.22-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$62.52-0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$45.76+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.22+0.09%

Questions About ALB

What is the current price of Albemarle?

Albemarle is trading at $114.40 per share.

What is the 52-week range for Albemarle?

Over the past 52 weeks, Albemarle has traded between $64.95 and $221.00.

How much debt does Albemarle have?

As of the most recent reporting period, Albemarle reported total debt of $2.01B.

How much cash does Albemarle have on hand?

Albemarle reported $1.09B in cash and cash equivalents in its most recent financial results.

What is Albemarle’s dividend yield?

Albemarle currently has a dividend yield of 1.41%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.